drugset
drugset / Trial / NCT03066869

Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis

NCT03066869 ↗

Phase 4 Unknown 40 enrolled Ocular Immunology and Uveitis Foundation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the short- and long-term efficacy and safety of Acthar for the treatment of adults with non-infectious retinal vasculitis.

Timeline

Start
2017-03-22
Primary completion
2020-02
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Repository Corticotropin Injection Unknown — —

Indications

retinal vasculitis